Mei Jiang
Neurology with Special Qualifications in Child Neurology · Las Vegas, NVNPI 1124386016
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 157 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by UCB, Inc. at 24.9% of the total. 2025 is the largest year on record at $1,419, 4.5 times the $315 reported in 2022.
Across 157 payments — averaging $25.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$979
- Acadia Pharmaceuticals Inc$417
- Jazz Pharmaceuticals Inc.$274
- NS Pharma, Inc.$231
- Sarepta Therapeutics, Inc.$229
- Catalyst Pharmaceuticals, Inc.$223
- plus $2K from 22 others
What the payments were for
- Food & beverage$3,932100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 38 | $979 |
| Acadia Pharmaceuticals Inc | 19 | $417 |
| Jazz Pharmaceuticals Inc. | 8 | $274 |
| NS Pharma, Inc. | 9 | $231 |
| Sarepta Therapeutics, Inc. | 8 | $229 |
| Catalyst Pharmaceuticals, Inc. | 12 | $223 |
| Neurelis, Inc. | 9 | $184 |
| Biogen | 7 | $180 |
| SK Life Science, Inc. | 2 | $156 |
| PTC Therapeutics, Inc. | 6 | $150 |
| AstraZeneca | 5 | $130 |
| Genentech USA, Inc. | 4 | $114 |
| Livanova USA, Inc. | 4 | $87 |
| Biocodex, Inc. | 3 | $84 |
| ITF Therapeutics LLC | 4 | $73 |
| Upsher-smith Laboratories LLC | 3 | $73 |
| Ironshore Pharmaceuticals Inc. | 2 | $53 |
| Aquestive Therapeutics, Inc. | 2 | $45 |
| Aucta Pharmaceuticals, Inc. | 3 | $39 |
| Pyros Pharmaceuticals, Inc. | 1 | $39 |
| Immedica Pharma US, Inc. | 1 | $37 |
| Springworks Therapeutics, Inc. | 1 | $26 |
| Nobelpharma America, LLC | 1 | $21 |
| Novartis | 1 | $19 |
| Cranial Technologies, Inc | 1 | $19 |
| Biomarin Pharmaceutical Inc. | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $18 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $16 |
How this compares
Too few neurology with special qualifications in child neurology providers in Nevadato place this figure against a meaningful peer group, so we don't.
Other neurology with special qualifications in child neurology in Las Vegas
- Devraj ChavdaLas Vegas$7K
- Rooman AhadLas Vegas$2K
- Gerardo RodriguezReno$11K
- Colin NguyenReno$4K
- Roshan RajaHenderson$4K
- Stacey KnoblerReno$3K
- Herbert EzughaHenderson$3K
- Monica ChaconHenderson$2K
- Tiffani McDonoughReno$286
- Shanti ThirumalaiReno$226
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.